Envision Pharma Group
Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and more to deliver smarter, faster outcomes for life sciences clients.
HORSHAM, UK / ACCESSWIRE / January 16, 2024 / Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) and a member of its Executive Leadership Team. In her new role, Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and more to deliver smarter, faster outcomes for life sciences clients.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page."I am so pleased to welcome Alice to the Envision team and her invaluable experience as a global life sciences industry leader," shares Howard Miller, CEO of Envision Pharma Group. "Alice brings a depth of strategic expertise, knowledge, and insight in the medical communications, scientific research, and publications field that will be instrumental in propelling our vision forward for our people and serving the needs of our clients."
Alice joins Envision from IPG Health where she most recently served as EVP, Managing Director, Client Solutions, APAC. Prior to this, the bulk of her career was in IPG Health Medical Communications - latterly as Chief Operating Officer for the group and formerly, as Head of Complete Medical Communications. During her tenure, she played a pivotal role in establishing and fulfilling long-term business goals while focusing on building upon key client relationships to foster sustained business growth, development, and operational excellence across several global teams.
Alice is committed to best practices and standards in medical communications, as demonstrated in her current role as Chair of the Healthcare Communications Association and through her success at IPG Health Medical Communications and former tenure as Chair of the International Society of Medical Publications Professionals (ISMPP).
Alice adds, "I have long admired the work done by Envision and am excited to be joining such a stellar team. Medical communications continue to move at a rapid pace, and I look forward to ensuring that we continue leading the field in terms of our people, our quality, and our innovative patient-centric services."
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 19 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.
Contact Information
Colleen Carter
Associate Director, Communications, Office of CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856
SOURCE: Envision Pharma Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Motorica Raises €5M to Lead the Generative AI Revolution in Character Animation24.6.2025 14:18:00 CEST | Press release
Trusted by top-tier AAA studios and animators, Motorica delivers production-ready motion synthesis at 200x speed, with no compromise on quality or control STOCKHOLM, SE / ACCESS Newswire / June 24, 2025 / Motorica, the global pioneer in Generative AI for character animation and motion synthesis, today announced the close of a €5 million seed funding round, led by Angular Ventures, with participation from Luminar Ventures. The funding will support Motorica's rapid expansion, scaling of its proprietary AI platform and continued investment in R&D to shape the future of instant character animation. Motorica's technology is already being used in live production environments by world-leading AAA studios to deliver production-ready animation at unprecedented speed and scale. In early deployments, studios have reported up to a 99% reduction in animation time, achieving animation workflows that are 200x faster than the traditional motion capture to gameplay animation workflow - without sacrific
MTN to Lead Europe's Future of Connectivity and Network Solutions from New European HQ in Paris, France24.6.2025 12:30:00 CEST | Press release
PARIS, FRANCE AND FT. LAUDERDALE, FL / ACCESS Newswire / June 24, 2025 / MTN, a fully owned subsidiary of FMC GlobalSat and the world's leading provider of converged satellite and wireless connectivity solutions, announced the opening of its new European headquarters in Paris, France. This move significantly expands the company's footprint in the region and enhances its operational capabilities, deepening its commitment to serve clients across the European market and beyond. Just a few minutes away from Place de La Madeleine, MTN located its new hub in Boulevard Malesherbes, right in the fast and busy heart of Paris. MTN is committed to establishing a center of excellence in the city, creating 50 highly skilled new positions initially and planning a multimillion-dollar investment in France. These roles will primarily focus on software development, IT, and engineering, reinforcing the company's commitment to innovation and technical expertise. Currently, MTN serves numerous French compa
Global Financial Institutions and Technology Leaders Collaborate Under FINOS to Launch Open Source Common Controls for AI Services24.6.2025 10:00:00 CEST | Press release
BMO, Citi, Microsoft, Morgan Stanley, RBC, Google Cloud, Red Hat, AWS and others join forces to set secure, standardized AI controls for financial services NEW YORK CITY, NY / ACCESS Newswire / June 24, 2025 / The Fintech Open Source Foundation (FINOS), part of the Linux Foundation, today announced the launch and cross-industry support behind its Common Controls for AI Services initiative - a collaborative effort to define standardized open source technology-neutral controls for safe and compliant AI adoption in the financial industry. Global financial institutions - including BMO, Citi, Morgan Stanley, RBC, are working with major cloud and technology providers, including Microsoft, Google Cloud and Amazon Web Services (AWS). These efforts are supported by consultants and vendors like Red Hat, Sonatype, ControlPlane, Scott Logic and Tetrate, working collaboratively to develop baseline AI controls tailored to the complex regulatory and operational requirements of the financial sector. W
ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology23.6.2025 15:00:00 CEST | Press release
BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic quality assurance. Leveraging phage-like particle encapsulated RNA technology, this product sets a new standard for accuracy and reliability in avian influenza (H5N1) detection, addressing critical gaps in laboratories' ability to validate end-to-end testing workflows. As H5N1 outbreaks continue to rise globally, the need for robust quality control materials has never been greater. ZeptoMetrix's Influenza A H5N1 Quantitative Stock offers laboratories a comprehensive quality control material that requires RNA extraction, unlike traditional naked RNA products. This novel solution includes three encapsulated H5N1 gene segments within a phage-like particle, ensuring realistic validation of extraction, amplification, and detection steps. "The ongoing H5N1 pandemic highlighted the urgent need
Geneva, Switzerland Set to Host World of Coffee Welcoming Thousands of Specialty Coffee Professionals and Enthusiasts23.6.2025 08:00:00 CEST | Press release
Trade Show and Conference to Feature Four Global Competitions and Much More GENEVA, SWITZERLAND / ACCESS Newswire / June 23, 2025 / The Specialty Coffee Association (SCA) is excited to welcome the global coffee community to World of Coffee Geneva, taking place June 26-28, 2025 at Palexpo SA. As Europe's premier international specialty coffee trade show, this year's event promises a dynamic schedule filled with inspiring workshops, prestigious global competitions, and engaging experiences designed to educate, connect, and energize coffee professionals from around the world. "We are thrilled to welcome the global coffee community to World of Coffee Geneva, opening June 26 in Switzerland, one of the most active European countries in the global specialty coffee industry and value chain," said Yannis Apostolopoulos, CEO of the Specialty Coffee Association. "Geneva is the perfect host city for bringing together industry leaders, entrepreneurs, and coffee lovers from around the world. We look
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom